Health Fitness Blog Sexual Health Cure and Beauty

Thursday, 11 December 2014

Mens health bad cum and semen related to mens health


Bad Cum means poor Mens health: Men's Health, connected to the sperm quality


Having poor sperm quality men were more likely to have high blood pressure, heart disease, skin diseases and endocrine diseases, a new study suggests.

Bad Cum means poor Mens health: Men's Health, connected to the sperm quality


According to Dr. Michael Eisenberg, assistant professor of urology and director of male reproductive medicine and surgery at Stanford University, who led the study, the problem is probably genetic.

About 15 percent of all couples have fertility problems, and in half of the cases the male partner sperm deficits, "Eisenberg said today.


"We need to pay more attention to the millions of men infertility is a warning. Reading problems can lead to health problems in general."


Men's health worsens with age. "But here, as signs of problems in young men in their 30s," says Eisenberg.


Published in the journal Fertility and Sterility, the study examined data from more than 9,000 men with fertility problems 1994-2011 to determine the cause of their infertility. With an average age of 38, most men were very young, and she started families.


The researchers studied the characteristics such as volume, concentration and motility of sperm sample usually by the men provided, reported the Financial Express.


The results show that almost half of the men had abnormal sperm or semen, and most had no obvious health problems.


However, 44 percent of the men had other health problems that fertility performed in addition to the problem in the clinic. Men with certain diseases of the circulatory system, including hypertension, vascular disease and heart disease had abnormal rates of sperm defects, reports the Daily Mail.


"For example, 56 percent of people without hypertension had normal semen quality but only 45 percent of men with hypertension had normal semen quality," said Dr. Eisenberg.


"The health of the people is closely correlated with sperm quality," he said. "Given the high incidence of infertility, we need to have a broader vision. How do we treat infertility in men, also to assess your overall health."

Studies have shown that genes may be involved, but that does not necessarily mean that it is a hereditary problem.


"Are the last 15 percent of the human genome involved in male reproduction, it is conceivable that other health problems are also associated with defects in fertility," Eisenberg said.

Thursday, 3 July 2014

Tuberculosis TB disease rate increased in Washington

The rate of tuberculosis TB disease increases in Washington


Tuberculosis cases has risen dramatically in Washington for the first time after several years of decline. 


Tuberculosis cases has risen dramatically in Washington for the first time after several years of decline.


Up to 13 percent of the 185 cases reported in 2012- the last year, 209 cases of tuberculosis (TB) were recorded. 

The tuberculosis rate in Washington has always been lower than the national average, but in 2013 its rate is higher corresponded to the national average. 

"TB can be very serious and even fatal disease. Treatment is difficult for people because it requires taking multiple medications for several months," State Board of Health said Dr. Kathy Lofy. 

"It is important for public health and the health of the community to remain vigilant and work together to fight against TB." 

TB is a dangerous disease. This is usually a bacterial infection which affects the lungs but attack other parts of the body. 

Most symptoms are fever, night sweats, fatigue, weight loss and a persistent cough. 

Some people can be infected with TB and have no symptoms. 

Immediate treatment with appropriate antibiotics is the key to survival and less severe symptoms. 

People with HIV or AIDS, people under 5 and over 50, and people whose immune systems are most at risk. 

The disease is spread through the air when an infected person coughs, sneezes or speaks, and breathe in other bacteria. 

Counties with the largest number of cases in 2013 were the king (114), Snohomish (26), Pierce (22), Spokane (7), Clark (5) and Thurston (5). 

Drug-resistant TB remains a threat to public health in Washington. This type of treatment of tuberculosis requires a longer period of time. 

Two cases resistant to the Department of State Health TB multi-drug were reported in 2013. 

Infection control procedures must prevent, so it does not spread in place in hospitals or care to avoid exposure to TB. 

TB are higher among racial and ethnic groups. Nearly 75 percent of 2,013 cases born in the state abroad. 

In 2013, 53.6 percent of all reported cases of tuberculosis in Washington were among Asians, followed by Hispanics (13.9 percent) and white (13.4 percent). 

American Indians and Alaska accounted for only 1.4 percent of TB cases in Washington in 2013. 

Health care providers, laboratory workers and health agencies must continue to work together to prevent the recurrence of tuberculosis. There are only 75 years, tuberculosis has killed nearly 1,000 state residents each year. In 2013, there were 16 deaths from TB. 

The disease burden continues to rise, especially in drug-resistant cases are becoming more common around the world. 

Also read:




While considerable work has been done to prevent the spread of the disease, tuberculosis is a long-term commitment that must be respected by the community health care and public health. 

Worldwide TB is a leading cause of death from infectious diseases. About nine million people infected with TB worldwide each year, and kills about two million.

Thursday, 19 June 2014

Designer T-cells Clear autoimmune disease, without immune side effect

Designer T-cells Clear autoimmune disease, without weakening the immune system


Successfully tested in mice, could this protocol lead to new ways to treat autoimmune diseases such as multiple sclerosis, rheumatoid arthritis and type 1 diabetes in people.


This protocol lead to new ways to treat autoimmune diseases such as multiple sclerosis, rheumatoid arthritis and type 1 diabetes in people.
Designer T-cells Clear autoimmune disease


Currently, the main treatment for autoimmune diseases comprising the suppression of inflammation by blocking the immune cells with anti-inflammatory drugs and steroids. While temporarily relieve the symptoms, these drugs can inhibit the immune system at the same time and leave the patient vulnerable to certain infections.

Therefore, scientists are trying a new type of treatment that target autoimmune and inflammatory immune cells without disturbing the immune system. Thus the power of immune system remains unaffected with this type of treatment.

New research highlighted in Science Translational Medicine, explains how researchers have developed specific T cells pathogenic immune cells without destroying immune system.


Facts about autoimmune diseases



Redesigning the immune system


The research was carried out and discovered by Shinpei Kasagi by the National Institutes of Health (NIH). Researchers have created an environment of immuno suppressed mice or experimental autoimmune encephalomyelitis with non-obese diabetes or an immune molecule with the call control of TGF-beta. Autoantigenic peptides were then injected in the animals; These peptides are the molecules to create the specific regulatory T cells and found in the differentiation of T cells specific for the antigen.

Regulatory T cells and inflammatory then allowed to go in the tissues and organs of mice. In essence the researchers, redesigned the immune system with regulatory T cells.

Scientists have found that regulatory newly generated T cells not only stopped the autoimmune disease, but the animals have remained free of disease after stopping the injection of peptides.


The key to the treatment is the insertion of T-cell auto-antigens specific regulator. The methods have been developed to reprogram differentiating T cells in native immune suppressor regulatory T cells, not T-cell pro-inflammatory effector cells, said Dr. Wanjun Chen, an NIH researcher. Once programmed, these autoantigens specific regulatory T-cells to regenerate, which is probably why the mice in the study continued to experience a remission after treatment.

It remains to be confirmed that it will be administered by the long-term remission of several peptides, Chen said.

"The efficacy and long-term and dramatic suppression of autoimmune diseases is better than expected," Chen said.

After treatment, the mice with normal immune system, bacterial antigens were suspended.


Looking to the future


What's next for this approach? The researchers say that they want to judge them, such as regulatory T cells work in animals with other autoimmune diseases such as arthritis, before clinical trials in humans.

Theoretically, the protocol could be used for other types of autoimmune diseases in mice and eventually in humans as a researcher identifies one or more autoantigens specific for the particular disease.

You may also like




"Maybe the type 1 diabetes and MS are diseases that need to be explored first," Chen said in a statement.

For now, Chen said, represents a big step toward the "holy grail" of immunology research, namely, how immune cells specifically without weakening the immune system of a patient.